Sung-Yeon Cho Selected Research

Sung-Yeon Cho Research Topics

Disease

8	Sepsis (Septicemia) 11/2021 - 03/2013
7	Infections 10/2022 - 10/2013
6	Neutropenia 12/2021 - 03/2013
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 09/2015
5	Invasive Fungal Infections 03/2020 - 09/2015
5	Aspergillosis 01/2020 - 12/2013
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2022 - 09/2015
4	Hematologic Neoplasms (Hematological Malignancy) 02/2018 - 09/2015
3	Hematologic Diseases (Blood Diseases) 04/2022 - 12/2013
3	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2020 - 10/2017
3	Bacteremia 08/2018 - 03/2013
2	Cytomegalovirus Infections (Inclusion Disease) 10/2022 - 05/2019
2	Pneumonia (Pneumonitis) 10/2022 - 01/2016
2	COVID-19 11/2021 - 01/2021
2	Neoplasms (Cancer) 02/2020 - 10/2016
2	Invasive Pulmonary Aspergillosis 01/2020 - 08/2018
2	Mucormycosis 01/2020 - 09/2015
2	Leukemia 02/2018 - 09/2014
2	Coinfection 04/2017 - 12/2014
2	Inflammation (Inflammations) 05/2016 - 03/2014
1	Colitis 10/2022
1	Encephalitis (Encephalitis, Rasmussen) 10/2022
1	Multiple Organ Failure (MODS) 10/2022
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2019
1	Breakthrough Infections 02/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	severe chronic Neutropenia 10/2017
1	Mycoses (Diseases, Fungus) 04/2017
1	Tuberculosis (Tuberculoses) 01/2017
1	Critical Illness (Critically Ill) 10/2016
1	Bacterial Infections (Bacterial Infection) 07/2016
1	Ototoxicity 01/2016
1	Urinary Tract Infections (Urinary Tract Infection) 01/2016
1	Diarrhea 10/2015
1	Mucositis 10/2015
1	Pyelonephritis 10/2014
1	Gas Gangrene (Gangrene, Gas) 09/2014
1	Disease Progression 09/2014
1	Appendicitis 09/2014
1	Shock 03/2013

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 10/2022 - 12/2013
5	posaconazole FDA Link 02/2020 - 09/2015
4	AzolesIBA 03/2020 - 08/2018
4	Voriconazole (Vfend)FDA LinkGeneric 08/2018 - 12/2013
2	Antiviral Agents (Antivirals)IBA 10/2022 - 05/2019
2	EnzymesIBA 11/2021 - 10/2015
2	Vancomycin FDA LinkGeneric 09/2021 - 10/2013
2	C-Reactive ProteinIBA 03/2014 - 03/2013
1	Foscarnet FDA LinkGeneric 10/2022
1	Leflunomide (Arava)FDA LinkGeneric 10/2022
1	Ganciclovir (Cytovene)FDA LinkGeneric 10/2022
1	Cidofovir (Vistide)FDA Link 10/2022
1	venetoclaxIBA 12/2021
1	Immunoglobulin A (IgA)IBA 11/2021
1	Neutralizing AntibodiesIBA 11/2021
1	Immunoglobulin M (IgM)IBA 11/2021
1	TriazolesIBA 02/2020
1	Proton Pump InhibitorsIBA 02/2020
1	TabletsIBA 02/2020
1	Calcium OxalateIBA 01/2020
1	thymoglobulin FDA Link 10/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2019
1	VaccinesIBA 05/2019
1	carbapenemaseIBA 08/2018
1	Antifungal AgentsIBA 02/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018
1	Decitabine FDA Link 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	TeicoplaninIBA 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2017
1	Ferritins (Ferritin)IBA 10/2017
1	Anti-Infective Agents (Microbicides)IBA 07/2016
1	Amikacin (A.M.K)FDA LinkGeneric 01/2016
1	SuspensionsIBA 10/2015
1	Carbapenems (Carbapenem Antibiotics)IBA 10/2014
1	Biomarkers (Surrogate Marker)IBA 03/2014
1	CytokinesIBA 03/2014
1	ProcalcitoninIBA 03/2014
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2013

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 12/2021 - 10/2013
5	Therapeutics 10/2022 - 12/2014
5	Hematopoietic Stem Cell Transplantation 04/2022 - 01/2017
3	Stem Cell Transplantation 03/2020 - 10/2013
3	Remission Induction 02/2020 - 09/2015
2	Immunotherapy 05/2019 - 05/2016
2	Early Goal-Directed Therapy 12/2014 - 03/2014
1	Cell Transplantation 10/2022
1	Combination Drug Therapy (Combination Chemotherapy) 12/2021
1	Length of Stay 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Central Venous Catheters 02/2018
1	Catheters 03/2013
1	Transplantation 03/2013